Wanshili: it will be listed on September 22

China's Road to Tackle Autoimmune Diseases Globally

The market of autoimmune diseases medication is vast both in China and overseas and presents great opportunities. However, the number of Chinese players specializing in autoimmune diseases is limited. This article introduced the autoimmune diseases medication market in China and explained why Chinese players are limited then give some recommendations on what efforts Chinese companies can make to compete with western players.

WH Group Splits US Food Spices Units Under Smithfield to Solina Group

France-based Solina is a leader in the market for savory ingredients and is majority-owned by European private equity firm Astorg.

15 Chinese Companies to Watch in September 2022 – New Consumption

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's new consumption space in September 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the companies operate.

15 Companies to Watch in September 2022- Healthcare

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in September 2022. And the following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, and the segments in which the startups operate.

Insight Lifetech Completes Series D+ Equity Round

Insight Lifetech, a high-tech company dedicated to providing innovative solutions for cardiovascular disease precision intervention, will continue to provide more innovative products and services and provide changes to precision diagnosis and treatment of cardiovascular diseases.